Failure to Advance Stated Goals:Dr. Bokhari and the Board have failed to achieve any of these objectives.
• While the Phase 2 Clinical Trial was approved in September 2020, to date only one patient has been enrolled in the trial out of an “expected” 352 patients.
• While the Company listed its Cobourg Property for sale in the first quarter of 2020, it remains unable to dispose of the property
. • Management has failed to identify any viable or appropriate strategic acquisition opportunities.